Insulin access and affordability are critical barriers to preventing acute and long-term diabetes complications, yet people with diabetes report lack of support and resources from health care providers, pharmaceutical companies, insurance companies, hospital systems, and pharmacies [6]. Here, INS is linked to diabetes mellitus.